Although eIF2Bδ has oncogenic relevance in other cancer types, e.g., breast cancer (Gupta et al, 2023), it seems an unsuitable target in CRC as modulation of its levels results in overall disrupted translational homeostasis leading to uncontrolled cell death. The gene discussed is EIF2B4; the disease is breast carcinoma.